Biophotonics Market Report 2026

The biophotonics market size has grown rapidly in recent years. It will grow from $92.07 billion in 2025 to $103.72 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to advancements in optical sensor technologies, increased funding for life sciences research, expansion of biomedical imaging applications, rising adoption of photonic tools in diagnostics, growth in academic and clinical research.

The biophotonics market size is expected to see rapid growth in the next few years. It will grow to $166.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of personalized medicine applications, rising integration of ai in optical imaging, growing use of biophotonics in minimally invasive therapies, increasing adoption of point-of-care diagnostic devices. Major trends in the forecast period include increasing use of optical imaging in diagnostics, rising adoption of non-invasive light-based therapies, growing integration of biophotonics in medical devices, expansion of high-resolution microscopy techniques, enhanced focus on real-time biological monitoring.

The rising demand for minimally invasive surgeries is anticipated to drive the growth of the biophotonics market in the coming years. Optical engineering and imaging technologies have become essential in minimally invasive procedures, allowing real-time visualization of tissue manipulation in remote internal areas. For example, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based nonprofit professional organization, reported that total surgical and non-surgical procedures grew by 3.4% in 2023, reaching 34.9 million. Consequently, the increasing number of minimally invasive surgeries performed worldwide each year is contributing to higher revenues in the biophotonics market.

Major companies in the biophotonics market are concentrating on creating innovative products such as bronchoscopes for advanced medical procedures. Bronchoscopes are medical tools used to inspect the interior of the respiratory system. For example, in September 2025, Olympus Corporation, a Japan-based manufacturer specializing in precision optics and medical devices, introduced the BF‑UCP190F, a new endobronchial ultrasound (EBUS) bronchoscope designed for lung lesion biopsy and advanced diagnostic procedures. The device has a slim 5.9 mm outer diameter and 170° upward angulation, enabling physicians to reach deep into the peribronchial region and access segmental and subsegmental airways more effectively. This launch enhances Olympus’ biophotonics portfolio by integrating optical imaging with real-time ultrasound guidance, meeting the rising demand for minimally invasive lung sampling and improving diagnostic accuracy in thoracic oncology.

In May 2024, Bruker Corporation, a US-based manufacturing company, acquired NanoString Technologies for $392.6 million. This acquisition will strengthen Bruker's capabilities in spatial biology, particularly with their nCounter Analysis System, which analyzes gene and protein expression with high sensitivity and accuracy. NanoString Technologies is a US-based provider of life science tools for translational research and molecular diagnostic products.

Major companies operating in the biophotonics market are Thermo Fisher Scientific Inc., OpGen Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co., Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments Plc, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Bioptics Inc.

North America was the largest region in the biophotonics market in 2025. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biophotonics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the biophotonics market by increasing costs of imported lasers, optical fibers, imaging sensors, photonic chips, and precision components used in diagnostic and therapeutic systems. Research institutions and medical device manufacturers in North America and Europe are most affected due to reliance on imported photonics hardware, while Asia-Pacific faces cost pressures on export-oriented component manufacturing. These tariffs are raising equipment procurement costs and slowing system upgrades. At the same time, they are encouraging domestic photonics manufacturing, regional R&D investments, and localized supply chain development for advanced biophotonics technologies.

The biophotonics market research report is one of a series of new reports that provides biophotonics market statistics, including biophotonics industry global market size, regional shares, competitors with a biophotonics market share, detailed biophotonics market segments, market trends and opportunities, and any further data you may need to thrive in the biophotonics industry. This biophotonics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biophotonics combines photonics and biology and is a multidisciplinary research area encompassing all light-based technologies applied to life sciences and medicine. It is utilized to observe, manipulate, and monitor biological processes across different levels of biology: cellular, tissue, molecular, and organismal.

The main product technologies in biophotonics are in vitro and in vivo. In vitro studies investigate microorganisms, cells, and biological molecules outside their natural biological environment. These studies in biology and its subfields are typically conducted in labware such as test tubes, flasks, Petri dishes, and microtiter plates, and are commonly referred to as test-tube investigations. The various applications include transparent imaging, internal imaging, spectromolecular analysis, surface imaging, microscopy, light therapy, biosensors, and others, and are utilized by multiple sectors such as diagnostics, therapeutics, testing, and more.

The biophotonics market consists of revenues earned by entities by providing services such as optical imaging services, spectroscopy services, biosensing and lab-on-a-chip analysis services, laser-based therapeutic services, microscopy and high-resolution imaging services, and real-time biological process monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biophotonics market also includes sales of optical coherence tomography systems, fluorescence microscopy systems, Raman spectroscopy instruments, multiphoton microscopy systems, biosensor devices, and laser excitation and scanning systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.